Elizabeth Nabel

Elizabeth Nabel

Chief Tech/Sci/R&D Officer chez OPKO HEALTH, INC.

Fortune : 25 M $ au 31/03/2024

72 ans
Commercial Services
Health Services
Health Technology

Profil

Elizabeth G.
Nabel
currently works at The Boys & Girls Clubs of Boston, Inc., as Director from 2014, Accolade, Inc., as Independent Director from 2021, The Broad Institute, Inc., as Director from 2012, Lasker Foundation, as Director, Partners Medical International, Inc., as Director, Medtronic Plc, as Independent Director from 2014, Moderna, Inc., as Independent Director from 2021, Lyell Immunopharma, Inc., as Independent Director from 2021, Ariadne Labs, as Director from 2012, National Academy of Sciences, as Member, American Academy of Arts & Sciences, as Member, National Academy of Medicine (United States), as Member, Association of American Physicians, as Member, OPKO Health, Inc., as Chief Medical Officer from 2022, American Society of Clinical Investigation, as Member, Partners In Health, as Trustee-Emeritus, and Longwood Fund Management LLC, as Advisor.
Dr. Nabel also formerly worked at Medtronic, Inc., as Independent Director from 2014 to 2015, National Heart, Lung & Blood Institute, as Director from 1999 to 2009, Moderna, Inc., as Independent Non-Executive Director from 2015 to 2020, abrdn Healthcare Investors, as Independent Trustee, abrdn Life Sciences Investors, as Independent Trustee, abrdn World Healthcare Fund, as Independent Trustee from 2018 to 2019, The Brigham & Women's Hospital, Inc., as President from 2010 to 2021, Modex Therapeutics Ltd., as Executive Vice President-Strategy from 2021 to 2022, Brigham & Women’s Physicians Organization, Inc., as President from 2010 to 2021, Harvard Medical School, as Professor from 2010 to 2021, Brigham & Women's, as President from 2010 to 2021, abrdn Healthcare Opportunities Fund, as Trustee, and Brigham, Inc. (Massachusetts), as President from 2010 to 2021.
Dr. Nabel received her undergraduate degree from St. Olaf College and doctorate degree from Weill Cornell Medical College.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
29/02/2024 19 912 459 ( 2,86% ) 24 M $ 31/03/2024
07/08/2023 13 651 ( 0,00% ) 1 M $ 31/03/2024
01/03/2024 24 071 ( 0,03% ) 252 264 $ 31/03/2024
07/03/2024 1 373 ( 0,00% ) 146 307 $ 31/03/2024
08/09/2023 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Elizabeth Nabel

SociétésPosteDébut
MEDTRONIC PLC Director/Board Member 01/01/2014
MODERNA, INC. Director/Board Member 10/03/2021
LYELL IMMUNOPHARMA, INC. Director/Board Member 01/04/2021
ACCOLADE, INC. Director/Board Member 02/06/2021
OPKO HEALTH, INC. Chief Tech/Sci/R&D Officer 01/05/2022
Consultant / Advisor -
Lasker Foundation Director/Board Member -
Director/Board Member 01/01/2014
Director/Board Member 01/01/2012
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░ ░░ ░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Tous les postes actifs de Elizabeth Nabel

Anciens postes connus de Elizabeth Nabel

SociétésPosteFin
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Elizabeth Nabel

Formation de Elizabeth Nabel

St. Olaf College Undergraduate Degree
Weill Cornell Medical College Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Elizabeth Nabel

Relations

100 +

Relations au 1er degré

31

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées5
OPKO HEALTH, INC.

Health Services

ACCOLADE, INC.

Technology Services

MEDTRONIC PLC

Health Technology

MODERNA, INC.

Health Technology

LYELL IMMUNOPHARMA, INC.

Health Technology

Entreprise privées23

Health Technology

Miscellaneous

Miscellaneous

Miscellaneous

Health Services

Modex Therapeutics Ltd.

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

American Society of Clinical Investigation

Commercial Services

National Heart, Lung & Blood Institute

Government

Brigham & Women’s Physicians Organization, Inc.

Commercial Services

Health Technology

Health Services

Lasker Foundation

Finance

Health Services

Miscellaneous

Health Services

Health Services

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Elizabeth Nabel